SLC22A8 and acute kidney injury: With the evidence that protamine has little to no interactions with the basolateral membrane transporters OAT-1, OAT-3, and OCT-2, the question still remains of how protamine interacts with vancomycin to delay the onset of AKI when co-administered with vancomycin.